drugset / Trial / NCT02341404

A Study of 2-hydroxyflutamide (Liproca Depot), Injected Into the Prostate in Patients With Localized Prostate Cancer

NCT02341404 ↗

Phase 2 Completed 23 enrolled Lidds AB Uppsala University · collab
NaSingle-groupOpen-labelTreatment

Summary

The primary aim of the study was to characterize and quantify the histopathological changes in the surgical specimens obtained in patients undergoing prostatectomy in addition to imaging changes (MRI) following a single injection of Liproca Depot in patients with localized prostate cancer.

Timeline

Start
2012-05
Primary completion
2015-05
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject HYDROXYFLUTAMIDE Small molecule — Other

Indications